Centene Corporation ($CNC) Stock Forecast: Up 5.8% Today

What is Centene Corporation?

Centene Corporation (CNC) recently announced robust Q1 earnings, surpassing both profit and revenue projections. The company also adjusted its yearly guidance, which resulted in a positive shift in the stock market today.

Why is Centene Corporation going up?

CNC stock is up 5.8% on Apr 28, 2026 13:40

• Centene (CNC) delivered outstanding Q1 earnings, posting a non-GAAP EPS of $3.37, significantly ahead of expectations. This impressive performance bolstered investor confidence and led to a bullish trajectory in the stock price.
• The company generated $49.94 billion in revenue, marking a 7.1% increase compared to the previous year. Additionally, the revised guidance for the year 2026 contributed to a favorable outlook among investors.
• Analysts responded positively, with firms such as Jefferies and BofA slightly raising their price targets, reflecting optimism in Centene's current performance and future potential.
• The surge in Centene's stock price can be attributed to the strong earnings report, adjusted guidance, and favorable investor sentiment following strategic moves like debt repayment.

CNC Price Chart

CNC Technical Analysis

CNC News

Centene Reports Strong Q1 Earnings, Raises Guidance

Centene reported strong Q1 earnings, with non-GAAP EPS of $3.37 surpassing expectations by $1.24 and revenue reaching $49.94 billion, a 7.1% year-over-year increase. The company also raised its 2026 premium and service revenue guidance by $1.0 billion to a range of $171.0 billion to $175.0 billion, and updated its 2026 GAAP diluted EPS guidance floor to greater than $2.37 and adjusted diluted EPS guidance floor to greater than $3.40. Analysts have reacted by modest price target increases, with Jefferies raising their target to $39 and BofA to $34, though both maintained their current ratings.

https://intellectia.ai/news/stock/centene-reports-strong-q1-earnings-raises-guidance

Centene: Q1 Earnings Snapshot

Centene Corp. reported a strong first quarter, with profit reaching $1.54 billion, or $3.11 per share. Adjusted earnings were $3.37 per share, surpassing Wall Street expectations. The healthcare company also exceeded revenue forecasts, posting $37.3 billion, and projects full-year revenue between $175.5 billion and $179.5 billion.

https://www.joplinglobe.com/region/national_business/centene-q1-earnings-snapshot/article_3311b5cc-0105-55db-b427-eb29b742bd40.html

Centene: Q1 Earnings Snapshot

Centene Corp. reported a strong first quarter with profits of $1.54 billion, or $3.11 per share. Adjusted earnings per share reached $3.37, significantly exceeding analyst expectations of $1.87. The healthcare company also surpassed revenue forecasts, posting $49.94 billion against an expected $47.47 billion, and projects full-year revenue between $187.5 billion and $191.5 billion.

https://www.kens5.com/article/syndication/associatedpress/centene-q1-earnings-snapshot/616-8efac44e-a56b-4c47-a8e6-b6162de83499

ELV (Elevance Health) Goodwill : $28,340 Mil (As of Mar. 2026)

Elevance Health's (ELV) goodwill was reported at $28,340 million as of March 2026. GuruFocus rates ELV with a GF Score of 76/100 and a GF Value of $520.92, indicating it is significantly undervalued despite having two warning signs. The article explains goodwill as an intangible asset from company acquisitions and provides historical data and comparative analysis within the Healthcare Plans industry.

https://www.gurufocus.com/term/good-will/ELV

Centene shares rise as investors position ahead of earnings and recent guidance reaffirmation

Centene (CNC) shares rose 3.0% today as investors anticipate the company's first-quarter 2026 earnings report. The stock's movement is attributed to the company's recent reaffirmation of its 2026 profit outlook and balance sheet actions, including a partial redemption of debt. Analyst ratings show a mixed but generally positive outlook, with a median price target of $41.5.

https://www.quiverquant.com/news/Centene+shares+rise+as+investors+position+ahead+of+earnings+and+recent+guidance+reaffirmation

Trending Today

Franklin Resources Inc. ($BEN) Stock Forecast: Up 5.7% Today

Incyte Corporation ($INCY) Stock Forecast: Down 2.2% Today

PACCAR Inc. ($PCAR) Stock Forecast: Down 5.4% Today

Allegion plc ($ALLE) Stock Forecast: Down 7.1% Today

Micron Technology Inc. ($MU) Stock Forecast: Down 5.4% Today

Verisk Analytics Inc. ($VRSK) Stock Forecast: Down 0.0% Today

Coca-Cola Company (The) ($KO) Stock Forecast: Up 5.2% Today

Amylyx Pharmaceuticals ($AMLX) Stock Forecast: Down 5.2% Today

Tandem Diabetes Care, Inc. ($TNDM) Stock Forecast: Down 5.5% Today

Power Integrations Inc. ($POWI) Stock Forecast: Down 5.3% Today

Centene Corporation Price History

01.03.2026 - CNC Stock was up 5.7%

• Centene Corporation (CNC) is a diversified healthcare company that provides programs and services to government-sponsored healthcare programs. Today, CNC experienced a strong bullish movement in the market.
• The bullish movement in CNC stock could be attributed to the positive sentiment in the healthcare sector following the strong performance of companies like UnitedHealth Group (UNH) and Elevance Health (ELV).
• The current market trend could be influenced by a recent analysis suggesting UnitedHealth Group might face a significant audit exposure, indirectly boosting CNC and emphasizing strength in the industry.
• Investor confidence in the healthcare sector, including CNC, may have been supported by a notable increase in stake in Elevance Health coupled with their positive Q4 earnings and FY 2026 guidance.
• The overall stability and growth potential of various healthcare companies, such as HCA Healthcare Inc., likely added to the positive market sentiment, further driving CNC's bullish movement.

11.02.2026 - CNC Stock was down 7.3%

• Reduction in stake by Capital World Investors in Molina Healthcare (MOH) may have signaled lack of confidence in the healthcare sector, impacting CNC's stock negatively.
• CNC's stock decline can be attributed to warnings of lower membership in Affordable Care Act plans and higher utilization patterns in specialty pharmacy, raising concerns about future revenue streams.
• The market's mixed performance with Centene lagging behind while BridgeBio Pharma led suggests a sector-specific issue affecting CNC rather than broader market conditions.
• Surge in Valero Energy and Baker Hughes stocks, driven by favorable oil prices, highlights a shift towards traditional energy sources, potentially diverting investor attention away from healthcare and renewable energy sectors like CNC and First Solar.

02.03.2026 - CNC Stock was up 5.2%

• CNC experienced a strong bullish movement today.
• The significant increase in stakes by HF Advisory Group LLC and Rockland Trust Co. in Elevance Health (ELV) could have positively impacted CNC's stock price, as ELV's strong financial performance and raised dividend likely boosted investor confidence in the healthcare sector.
• Leerink's report on UnitedHealth Group (UNH) facing substantial RADV audit exposure might have indirectly benefited CNC, as investors may have shifted their focus towards other healthcare companies with potentially lower audit risks.
• Overall, the positive sentiment surrounding healthcare stocks, driven by strong financial results and strategic investments, likely contributed to CNC's bullish market movement today.

16.03.2026 - CNC Stock was up 5.0%

• CNC is a leading manufacturer of precision tools and equipment for woodworking and metalworking industries. The company has been expanding its product line and market presence, driving strong investor interest.
• An announcement of a cash dividend payout by MetroCity Bankshares could have positively impacted CNC's stock, indicating a healthy financial market environment.
• The AI arms race in the healthcare sector causing prior authorization issues and reimbursement cuts may have indirectly boosted CNC's stock as investors seek alternative industries for growth.
• A price target adjustment on HCA Healthcare by Baird could have led investors to reallocate funds to CNC, viewing it as a more promising investment opportunity.
• Assetmark Inc.'s increased stake in Elevance Health might have signaled confidence in the healthcare sector, indirectly benefiting CNC as part of a broader market sentiment shift.

28.03.2026 - CNC Stock was up 5.8%

• Centene (CNC) delivered outstanding Q1 earnings, posting a non-GAAP EPS of $3.37, significantly ahead of expectations. This impressive performance bolstered investor confidence and led to a bullish trajectory in the stock price.
• The company generated $49.94 billion in revenue, marking a 7.1% increase compared to the previous year. Additionally, the revised guidance for the year 2026 contributed to a favorable outlook among investors.
• Analysts responded positively, with firms such as Jefferies and BofA slightly raising their price targets, reflecting optimism in Centene's current performance and future potential.
• The surge in Centene's stock price can be attributed to the strong earnings report, adjusted guidance, and favorable investor sentiment following strategic moves like debt repayment.

20.02.2026 - CNC Stock was down 5.2%

• CNC experienced a strong bearish movement today.
• The decrease in CNC's stock price can be attributed to a lowered price target for the company from $45.00 to $41.00, along with a Neutral rating.
• This adjustment, combined with other revisions to price targets from various firms, has resulted in a varied sentiment among analysts regarding CNC's future performance.
• The overall negative trend in the healthcare sector, as illustrated by Molina Healthcare Inc. lagging behind its competitors, may have also adversely affected CNC's stock price today.

23.03.2026 - CNC Stock was up 5.0%

• CNC, alongside Molina Healthcare and other managed care companies, experienced a notable increase in their stock prices, suggesting a sector-wide upturn in healthcare plan providers.
• This surge in CNC's stock was driven by general investor optimism towards the healthcare industry, rather than any company-specific developments.
• The favorable performance of CNC could be linked to the overall positive outlook on managed care stocks and the healthcare sector at large.
• It is advisable for investors to closely track CNC's progress and watch for any potential new drivers that could sustain or further enhance its recent gains.

26.02.2026 - CNC Stock was up 5.1%

• CNC witnessed a notable uptick in its stock price today, potentially reflecting investor confidence in the company's operational resilience and diversification strategy in light of industry challenges.
• The recent 3.00% decline in CNC shares on March 25 appears to be a temporary market response, as financial analysts remain positive with an average target price of $45.71, suggesting considerable growth potential.
• The forthcoming April 25 earnings release is pivotal for CNC, with investors keenly observing how the company addresses rising Medicaid expenses and changes in its membership profile, seeking indications of financial stability and strategic direction in government healthcare.

23.02.2026 - CNC Stock was down 5.1%

• CNC stock faced a bearish movement possibly due to analyst pressure amid healthcare sector headwinds and mixed forecasts, leading to a cautious "Hold" consensus.
• The increased scrutiny on Acadia Healthcare Co, a competitor in the behavioral health sector, due to a US Justice Department probe may have raised concerns about regulatory risks in the industry, impacting CNC's stock valuation.
• The comparison between UnitedHealth Group (UNH) and CNC, with UNH being highlighted for its consistent growth and profitability, might have also influenced investors to shift towards more stable options in the healthcare sector.
• The overall uncertainty in the healthcare industry, coupled with Centene's specific challenges such as Medicaid reimbursement issues and rising medical costs, could have contributed to the bearish movement in CNC stock today.

23.02.2026 - CNC Stock was down 5.0%

• Challenges in Medicaid reimbursement and rising medical costs are putting pressure on Centene Corp., resulting in a cautious sentiment and a consensus to "Hold."
• The decline in CNC's stock could be influenced by mixed performance indicators, including bearish trends in MACD, Bollinger Bands, and KST.
• The scrutiny faced by companies like Acadia Healthcare Co and HCA Healthcare Inc, within the healthcare sector due to regulatory issues and operational uncertainties, may have contributed to the negative sentiment surrounding CNC.
• The prevailing headwinds in the healthcare sector and uncertainties in the US healthcare landscape could have played a role in the drop in Centene Corp.’s stock value today.

12.02.2026 - CNC Stock was down 5.2%

• A price target cut on Centene Corp. following its fourth-quarter results and concerns about future challenges likely contributed to the bearish movement.
• The overall U.S. HMO industry, including Centene, is facing challenges such as escalating medical costs and regulatory hurdles, despite leveraging technology and M&A for expansion.
• Reducing its stake in UnitedHealth Group may have impacted market sentiment towards health insurance companies like Centene.
• Despite the industry's challenges, Centene and other key HMO companies are positioned for long-term growth, as highlighted by Zacks Equity Research, which could provide some optimism for investors amidst the bearish market movement.

24.02.2026 - CNC Stock was down 5.6%

• The bearish movement in CNC's stock could be influenced by the overall mixed market sentiment towards healthcare companies and regulatory pressures.
• The positive earnings report from Jabil Inc. and the subsequent sector-wide rally might have shifted investor focus away from CNC, impacting its stock performance negatively.
• CNC might also be facing specific challenges or concerns within the healthcare sector, leading to a reevaluation of its prospects by investors.
• While CNC's performance today was bearish, it could present a potential buying opportunity for investors looking to capitalize on any short-term market fluctuations in the healthcare industry.